SCHEMBL658741

SCHEMBL658741

CC(C)(C)Sc1c(Br)cncc1C=O

nearest known ligand 0.33

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 1/20 0.33
AOC3 Q16853 1/20 0.32
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL658477 0.79 MEN1 (0.31)
SCHEMBL658478 0.79 MEN1 (0.31)
SCHEMBL658069 0.74 CYP2A6 (0.38) PRKDCLMNA
SCHEMBL31303112 0.72 AOC3 (0.42) PRKDCAOC3
SCHEMBL25234795 0.72 AOC3 (0.42) PRKDCAOC3
SCHEMBL30191342 0.71 LMNA (0.37) PRKDCLMNA
SCHEMBL112640 0.71 LMNA (0.37) PRKDCLMNA
SCHEMBL660309 0.71 ERN1 (0.37) PRKDCLMNA
SCHEMBL28953827 0.69 PRKDC (0.33) PRKDCLMNA
SCHEMBL658808 0.69 ERN1 (0.34) PRKDCLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250049035-A1 MICROBIOCIDAL BICYCLE HETEROCYCLIC DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2025-02-13 US disclosed
EP-4448534-A1 MICROBIOCIDAL BICYCLE HETEROCYCLIC DERIVATIVES Syngenta Crop Protection AG (CH) 2024-10-23 EP disclosed
CN-118339167-A Microbiocidal bicyclic heterocyclic derivatives 先正达农作物保护股份公司 2024-07-12 CN disclosed
WO-2023110869-A1 MICROBIOCIDAL BICYCLE HETEROCYCLIC DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2023-06-22 WO disclosed
WO-2023110869-A1 MICROBIOCIDAL BICYCLE HETEROCYCLIC DERIVATIVES SYNGENTA CROP PROTECTION AG (CH) 2023-06-22 WO disclosed
US-8378104-B2 7-aminofuropyridine derivatives OSI Pharmaceuticals, LLC (US) 2013-02-19 US disclosed
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES OSI PHARMACEUTICALS, INC. 2012-02-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250049035-A1 MICROBIOCIDAL BICYCLE HETEROCYCLIC DERIVATIVES NOX1, CASP1, CYP1A1 PRKDC 1103/4885AOC3 107/4885LMNA 3592/4885
US-20120046267-A1 7-AMINOFUROPYRIDINE DERIVATIVES MAP3K5, STK17A, MAPKAPK5 PRKDC 738/4885AOC3 3163/4885LMNA 3566/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.